Hengrui Medicine (01276): SHR-8068 Injection approved for clinical trials.

News from Securities Times APP: Hengrui Pharmaceuticals (01276) announced that recently, its subsidiary Suzhou Shengdiya Biomedical Pharmaceutical Co., Ltd. received the approval and issuance of the "Drug Clinical Trial Approval Notice" from the National Medical Products Administration for SHR-8068 injection, and will soon commence clinical trials.